-
2023-507633-21-00
5
Neurological Disease
-
2023-507427-28-00
5
seasonal allergic rhinitis and/or rhinoconjunctivitis
-
2025-522791-92-00
5
Neoplasm Metastasis
-
2025-522983-33-00
5
Chronic rhinosinusitis with nasal polyps
-
2025-524289-56-00
6
Asthma
-
2025-524316-11-00
5
Primary Progressive Multiple Sclerosis (PPMS)
-
2025-520466-22-00
5
2026-04-29
Advanced Platinum-resistant Epithelial Ovarian Cancer
-
2024-518589-29-00
5
2025-08-21
Bronchiectasis
-
2023-507633-21-01
5
2024-12-09
Multiple Sclerosis
-
2023-503290-38-00
4
2023-09-05
Bronchiectasis
-
2022-501007-28-00
5
2023-04-18
Breast Neoplasms
-
2024-516066-11-00
5
2022-08-31
Patients with newly diagnosed, histologically confirmed, primary advan
-
2025-524580-21-00
10
2026-06-01
Grass pollen induced allergic rhinitis or rhinoconjunctivitis
-
2025-521546-23-00
5
2026-04-21
Secondary progressive multiple sclerosis
-
2025-521762-99-00
5
2026-03-09
acute ischemic stroke
-
2025-521744-37-00
5
2025-11-17
Mild to moderate major depressive disorder
-
2024-519929-38-00
4
2025-10-27
Metastatic Colorectal Cancer without liver metastases
-
2024-514822-21-00
5
2025-10-02
Platinum-resistant Ovarian Cancer
-
2025-520473-40-00
4
2025-09-29
Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)
-
2024-516982-35-00
5
2025-09-11
Ovarian Cancer
-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2024-519525-38-00
5
2025-08-22
Heart failure
-
2024-517458-90-00
5
2025-06-06
Chronic obstructive pulmonary disease (COPD)
-
2024-515162-13-00
5
2025-04-29
Eosinophilic Asthma